Federal budget issues
2025 · 4th Quarter (Oct 1 - Dec 31)
VERTEX PHARMACEUTICALS INCORPORATED
Filed by TARPLIN, DOWNS & YOUNG, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- TARPLIN, DOWNS & YOUNG, LLC
- Filing UUID
- 4ed12d33-8716-43dd-8c1a-fb668881bf1b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Alternatives to PAIN Act, IRA, innovation, health disparities, orphan drugs, drug pricing in federal programs, opioid alternative medicines, SUPPORT Act reauthorization, awareness of rare kidney disorders
Medicare & Medicaid payment and coverage issues
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.